Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Advanced Course on Precision Oncology in Oncogene-Addicted NSCLC: EGFR, ALK, ROS, MET 2023: Barcelona

23 - 24 Jun 2023

Barcelona, Spain


Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Learning Objectives
  • To understand the biology of specific oncogene addicted NSCLC and the rationale for targeted treatment
  • To review the targeted treatment strategies, including current approvals and ongoing trials, in patients with oncogene addicted NSCLC
  • To learn about the best current practice regarding testing methodology and get an outlook on future developments
  • To improve interdisciplinary collaboration between oncology and pathology by understanding individual challenges in testing and treatment
  • To understand health-economical aspects of targeted treatment in NSCLC

This event has been supported by an unrestricted educational grant from Janssen, Roche and ThermoFisher.

Filter by:

There are 18 resources available

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.